Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Vivani Medical, Inc.EYES · Entity 6636 | Chief Operating Officer | February 19, 2020 | February 21, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Vivani Medical, Inc.
Report date February 19, 2020 · Filed February 21, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,594 |
Reported balance
After 2020-02-19 transaction · row 1
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 1 · 2020-02-19 · Grant · Acquired 3,594 · Balance 3,594 F1: 3,594 shares of common stock acquired upon partial vesting and release of common stock from restricted stock units(RSUs). |
| Common StockSEC Table I · non-derivative | Direct | 2,261 |
Reported balance
After 2020-02-20 transaction · row 2
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 2 · 2020-02-20 · Disposition to issuer · Disposed 1,133 · Balance 2,261 F2: 1,133 shares were sold to satisfy the tax withholding obligations on vesting and release of common stock from RSUs |
| Restricted Stock Units(RSUs)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2023-02-19 | Direct | 10,781 |
Reported balance
After 2020-02-19 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2020-02-19 · Exercise / conversion · Disposed 3,594 · Balance 10,781 F3: The RSUs vest over four years, in equal annual installments, subject to continuous employment. |
Filing footnotes · ownership attribution and instrument terms
F1: 3,594 shares of common stock acquired upon partial vesting and release of common stock from restricted stock units(RSUs).
F2: 1,133 shares were sold to satisfy the tax withholding obligations on vesting and release of common stock from RSUs
F3: The RSUs vest over four years, in equal annual installments, subject to continuous employment.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 20, 2020 Filed Feb 21, 2020 22:29 UTC | Vivani Medical, Inc. EYES · Entity 6636 | Disposition to issuerCommon Stock | 1,133 | $5.84 | $6,616.72 |
DisclosureSEC source: 0001209191-20-011662 · doc4.xml · nonDerivative · entry 2 RYAN WILLIAM PATRICK · CIK 0001519007 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,261 F2 · shares: 1,133 shares were sold to satisfy the tax withholding obligations on vesting and release of common stock from RSUs Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 22:29 UTC | Vivani Medical, Inc. EYES · Entity 6636 | Exercise / conversionRestricted Stock Units(RSUs) · Derivative | 3,594 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-011662 · doc4.xml · derivative · entry 3 RYAN WILLIAM PATRICK · CIK 0001519007 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,781 Underlying: Common Stock · 14,375 shares Expires 2023-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The RSUs vest over four years, in equal annual installments, subject to continuous employment. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 22:29 UTC | Vivani Medical, Inc. EYES · Entity 6636 | GrantCommon Stock | 3,594 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-011662 · doc4.xml · nonDerivative · entry 1 RYAN WILLIAM PATRICK · CIK 0001519007 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,594 F1 · shares: 3,594 shares of common stock acquired upon partial vesting and release of common stock from restricted stock units(RSUs). Read SEC document |
| February 12, 2020 Filed Feb 14, 2020 19:19 UTC | Vivani Medical, Inc. EYES · Entity 6636 | GrantNon-Qualified Stock Option(right to buy) · Derivative | 28,305 | $0.00 Strike: $5.98 | $0.00 |
DisclosureSEC source: 0001209191-20-009545 · doc4.xml · derivative · entry 1 RYAN WILLIAM PATRICK · CIK 0001519007 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,305 Underlying: Common Stock · 28,305 shares Expires 2030-02-12 F1 · derivative.exercise_date: The stock options have a 10-year term and vest over four years from the grant date in equal monthly installments, subject to continuous employment, such that the total number shall be fully vested on the four-year anniversary of the transaction date. Read SEC document |
| February 19, 2019 Filed Feb 22, 2019 00:42 UTC | Vivani Medical, Inc. EYES · Entity 6636 | GrantRestricted Stock Units(RSUs) · Derivative | 115,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-012318 · doc4.xml · derivative · entry 2 RYAN WILLIAM PATRICK · CIK 0001519007 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,000 Underlying: Common Stock · 115,000 shares Expires not disclosed F2 · derivative.exercise_date: The RSUs will vest over four years, in equal annual installments, subject to continuous employment. F2 · derivative.expiration_date: The RSUs will vest over four years, in equal annual installments, subject to continuous employment. Read SEC document |
| February 19, 2019 Filed Feb 22, 2019 00:42 UTC | Vivani Medical, Inc. EYES · Entity 6636 | GrantNon-Qualified Stock Option(right to buy) · Derivative | 229,000 | $0.00 Strike: $0.74 | $0.00 |
DisclosureSEC source: 0001209191-19-012318 · doc4.xml · derivative · entry 1 RYAN WILLIAM PATRICK · CIK 0001519007 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,000 Underlying: Common Stock · 229,000 shares Expires 2029-02-19 F1 · derivative.exercise_date: The stock options have a 10-year term and vest over four years from the grant date in equal monthly installments, subject to continuous employment, such that the total number shall be fully vested on the four-year anniversary of the transaction date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.